Lv2
178 积分 2025-03-16 加入
Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018-01 NIVOPOST-OP): a randomised, open-label, phase 3 trial
1天前
已完结
生成式人工智能服务管理暂行办法
2个月前
已完结
The Efficacy and Safety of Trastuzumab in the Metastatic Breast Cancer
3个月前
已完结
Efficacy and safety of abemaciclib plus endocrine therapy versus endocrine therapy alone in HR + and HER2-negative breast cancer; a systematic review and meta-analysis
8个月前
已完结
Efficacy and safety of abemaciclib plus endocrine therapy versus endocrine therapy alone in HR + and HER2-negative breast cancer; a systematic review and meta-analysis
8个月前
已完结
Dalpiciclib (Dalp) plus endocrine therapy (ET) as adjuvant treatment for HR+/HER2– early breast cancer (BC): The randomized, phase 3, DAWNA-A trial
11个月前
已完结
Integration of Postoperative Radiation Therapy with Cyclin-Dependent Kinase (CDK) Inhibitors
11个月前
已完结
Integration of Postoperative Radiation Therapy with Cyclin-Dependent Kinase (CDK) Inhibitors
11个月前
已关闭
Integration of Postoperative Radiation Therapy with Cyclin-Dependent Kinase (CDK) Inhibitors
11个月前
已关闭
CONCURRENT USE OF ABEMACICLIB AND RADIOTHERAPY IN METASTATIC BREAST CANCER PATIENTS: A SINGLE CENTRE EXPERIENCE
11个月前
已完结
皖公网安备34019202002308
